SUSMITA NANDI

• Responsible for operations management and delivery of localized commercial insights and analytics for region APMA, China, Japan and early stage portfolio simulation projects with account PNL of USD ~5M
• Involved in field decision science projects like Channel Impact Optimization for field representatives, 'go -to-market and customer experience strategy for 20+ markets across APMA and RE, supporting business in maximizing objectives of sales growth (~1.8% growth impact), market share growth (0.03% impact), optimization of personal promotion costs etc.
• Established innovative hubs like Field Decision Science and Augmented Real-Time analytics within function, with 5 productized business offering and USD 0.8M in business impact within 15 months of incubation Industrialization of 15+ innovation & continuous improvement with a focus in the areas of sales and medical reps journey, and commercial excellence
• Support 3+ enterprise-wide programs involving customer engagement and experience
• Develop human capital across 50+ associates and build 2 ground-up high-performance teams with focused capabilities to support Novartis transformation

• Responsible for the operations management and delivery executions of primary market research team of 100+ associates for top 7 Pharma clients in the US, EU and LatAM markets
• Led 3 global technical migration projects by transforming current manual mode of calculating KPIs and inputting business rules in the ETL tool to error-free and efficient output, resulting in 5x reduction of effort (80-90% processing time reduction; 50% headcount reduction) and generating saving of 1+ million USD. Migration involved evolving PMR report generation using Excel VBA dashboard and PPT to using tools like RapidMiner and QlikSense. Published a whitepaper on the business automation project
• Created innovation hub to create offerings using technical platforms that leverages NLS, AIML and predictive modeling to create solutions around augmented analytics. The deeper insights and predictive paths will provide clients with value-add and will enable them to make better decisions – potential revenue generation per year $600 USD
• Supported the automation of Patient Analytics reporting by identifying inefficient SQL codes to fetch data from large database to manual updating of data and converted into automated process

• Developed knowledge assets in the Life Sciences industry by creating an online portal of end-to-end business processes including the technical tools and applications, business KPIs mapped to a function and the quantified impact of application failures on business. This included case studies, dashboards, Analytical trends, functional landscape and processes, which have been used as a sales tool and for business development through BPF methodology
• Developed and implemented a quantitative measurement mechanism to capture incremental benefits to business through improvements in business or technical KPIs using the business process focus methodology
• Delivered analytics-based projects to top Life Science clients
• Identified inefficient business processes for potential implementation of domain BOTs (automation) to improve efficiency
• Played the role of a consulting in the core BD&L solution team, to support responding to RFP and bid defense that involved on-site visits (Paris and London)

• Supported the Respiratory franchise in shaping their brand and pipeline strategy by providing actionable insights and market intelligence (situation analysis, competitive analysis, risk & opportunity analysis, unmet needs, patient journey)
• Supported the launch of TOBI inhaler and post launch market intelligence for Xolair
• Performed analysis of complex business problems by consolidating data from various sources, including intelligence from Congresses and other events to provide key inputs related to shaping of brand strategy
• Provided key insights to clinical development team- for example, there is a high correlation between infants having allergic rhinitis and developing asthma as adults
• Developed Analytics reports to measure global adoption of in-market brands in terms of new prescriptions and regional sales performance using IMS PADDS and other data

• Set up team to develop patient-based forecasting model for Respiratory therapy area including creating channels for inputs from pricing, competitive intelligence, market research data etc
• Responsible for training forecasting methodology to the Australia country marketing and sales team to improve the alignment between global and country forecasts (traveled to Sydney)
• Provided forecasts and business analysis to the Strategic Marketing and BD&L teams to support key decisions on pipeline development and risk assessment
• Supported other therapy areas like Cardiovascular and Neuroscience

1. Led analytics-based consulting projects by creating model based solutions with the objective of solving clients' business problems

2. Developed a multi-skilled team to create end-to-end product for the client by collaborating with data science, BI and technology teams

1. Responsible for a 100+ delivery team in the area of Pharma research and analytics projects

2. Responsible for client account management and BD&L support